Hematology

Hodgkin Lymphoma Molecular Profiling and Clinical Outcomes in U.S. Community Oncology Practices
More Information

A Study Of PF-05280586 (Rituximab-Pfizer) Or MabThera® (Rituximab-EU) For The First-Line Treatment Of Patients With CD20-Positive, Low Tumor Burden, Follicular Lymphoma (REFLECTIONS B328-06)
More Information

A Disease Registry of Patients With Mantle Cell Lymphoma (SUMMIT)
More Information

Phase 2 Study of Ruxolitinib Versus Anagrelide in Subjects With Essential Thrombocythemia Who Are Resistant to or Intolerant of Hydroxyurea (RESET-272)
More Information

A Study of INCB050465 in Subjects With Relapsed or Refractory Marginal Zone Lymphoma (CITADEL-204)
More Information

A Study of INCB050465 in Relapsed or Refractory Mantle Cell Lymphoma Previously Treated With or Without a Bruton’s Tyrosine Kinase (BTK) Inhibitor (CITADEL-205)
More Information

HMPL-760 Safety and Tolerability Study in Patients With Previously Treated CLL/​SLL or NHL
More Information

The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies (OPAL)
More Information

A Study of INCB050465 in Combination With Ruxolitinib in Subjects With Myelofibrosis
More Information

Zandelisib (ME-401) in Subjects With Follicular Lymphoma or Marginal Zone Lymphoma After Failure of Two or More Prior Therapies (TIDAL)
More Information

Oncology

To Assess the Safety, Tolerability and Efficacy of Itacitinib Immediate Release Tablets in Participants With Primary or Secondary Myelofibrosis Who Have Received Prior Ruxolitinib and/​or Fedratinib Monotherapy (LIMBER-213)
More Information

Phase 2 Window Study of SAR439859 (Amcenestrant) Versus Letrozole in Post-menopausal Patients With ER+, HER2- Pre-operative Post-menopausal Primary Breast Cancer (AMEERA-4)
More Information

A Study of DSP-7888 Dosing Emulsion in Combination With Bevacizumab in Patients With Recurrent or Progressive Glioblastoma Following Initial Therapy
More Information

A Study of Tislelizumab (BGB-A317) in Combination With Chemotherapy as First Line Treatment in Participants With Advanced Esophageal Squamous Cell Carcinoma
More Information

EndoTAG-1+GEM vs GEM in Patients With Locally Advanced/​Metastatic Pancreatic Adenocarcinoma Failed on FOLFIRINOX
More Information

Prevalence of PD-L1 Expression in Patients With Advanced Urothelial Carcinoma (PREVAIL)
More Information

Study of Durvalumab With Chemoradiotherapy for Women With Locally Advanced Cervical Cancer (CALLA) (CALLA)
More Information

Blood Sample Collection in Subjects With Pulmonary Nodules or CT Suspicion of Lung Cancer or Pathologically Diagnosed Lung Cancer
More Information

Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Solid Tumors
More Information

A Study of INCMGA00012 in Squamous Carcinoma of the Anal Canal Following Platinum-Based Chemotherapy (POD1UM-202)
More Information

A Study of Abemaciclib (LY2835219) in Combination With Fulvestrant Compared to Chemotherapy in Women With HR Positive, HER2 Negative Metastatic Breast Cancer
More Information

A Study of ASP8273 in Subjects With Non-small Cell Lung Cancer (NSCLC) Harboring Epidermal Growth Factor Receptor (EGFR) Mutations
More Information

Bempegaldesleukin and Pembrolizumab With or Without Chemotherapy in Locally Advanced or Metastatic Solid Tumors (PROPEL)
More Information

Phase 3 Trial of Elacestrant vs. Standard of Care for the Treatment of Patients With ER+/​HER2- Advanced Breast Cancer (EMERALD)
More Information

A Study of Weekly Tisotumab Vedotin for Patients With Platinum-Resistant Ovarian Cancer With Safety Run-in (innovaTV 208)
More Information

A Study for Subjects Who Are Participating in an Astellas-sponsored ASP8273 Study
More Information

A Study of ASP8273 in Subjects With Non-small Cell Lung Cancer (NSCLC) Harboring Epidermal Growth Factor Receptor (EGFR) Mutations
More Information

To Evaluate the Efficacy and Safety of Parsaclisib and Ruxolitinib in Participants With Myelofibrosis (LIMBER-313)
More Information

HMPL-760 Safety and Tolerability Study in Patients With Previously Treated CLL/​SLL or NHL
More Information

APX005M With Concurrent Chemoradiation for Resectable Esophageal and Gastroesophageal Junction Cancers
More Information

Study of BGB-290 or Placebo in Participants With Advanced or Inoperable Gastric Cancer
More Information

Hodgkin Lymphoma Molecular Profiling and Clinical Outcomes in U.S. Community Oncology Practices
More Information

Study of Amcenestrant (SAR439859) Versus Tamoxifen for Patients With Hormone Receptor-positive (HR+) Early Breast Cancer, Who Have Discontinued Adjuvant Aromatase Inhibitor Therapy Due to Treatment-related Toxicity (AMEERA-6)
More Information

Evaluation of Efficacy and Safety of Neoadjuvant Treatment With Pamrevlumab in Combination With Chemotherapy (Either Gemcitabine Plus Nab-paclitaxel or FOLFIRINOX) in Participants With Locally Advanced, Unresectable Pancreatic Cancer (LAPIS)
More Information

A Study of Tiragolumab Plus Atezolizumab Compared With Placebo Plus Atezolizumab in Participants With Completely Resected Non-small Cell Lung Cancer Who Have Received Adjuvant Platinum-based Chemotherapy (SKYSCRAPER-15)
More Information

Efficacy and Safety of Pemigatinib in Subjects With Advanced/​Metastatic or Surgically Unresectable Cholangiocarcinoma Who Failed Previous Therapy – (FIGHT-202)
More Information

A Study to Evaluate SHR-1210 in Combination With Apatinib as First-Line Therapy in Patients With Advanced HCC
More Information

Pulmonology

A Study to Assess the Efficacy and Safety of Budesonide/​Albuterol Metered-dose Inhaler (BDA MDI/​PT027) in Adults and Children 4 Years of Age or Older With Asthma (MANDALA)
More Information

Efficacy and Safety of BI 655066/​ABBV-066 (Risankizumab) in Patients With Severe Persistent Asthma
More Information

An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects (BEAM)
More Information

Study of Efficacy and Safety of QAW039 in Patients With Severe Asthma Inadequately Controlled With Standard of Care Asthma Treatment.
More Information

Study of Safety of QAW039 in Patients With Asthma Inadequately Controlled on Standard-of-care Asthma Treatment
More Information

Evaluation of the Efficacy and Safety of VX-814 in Subjects With the PiZZ Genotype
More Information

Stage 1 Study of ARALAST NP and GLASSIA in A1PI Deficiency
More Information

GLASSIA Safety, Immunogenicity, and Bronchoalveolar Lavage Study
More Information

A 6-week Dose Ranging Study of CHF 5259 pMDI in Subjects With Chronic Obstructive Pulmonary Disease (GLIMMER)
More Information

Evaluation of Dupilumab in Patients With Persistent Asthma (Liberty Asthma Quest)
More Information

Zephyrus I: Evaluation of Efficacy and Safety of Pamrevlumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
More Information

Effect of Switching From Cigarette Smoking to THS on Disease Progression in Mild to Moderate COPD Subjects With Chronic Bronchitis Symptoms
More Information

Study to Assess the Efficacy and Safety of PT010 Relative to PT003 and PT009 in Subjects With Moderate to Very Severe COPD (Ethos)
More Information

Mechanistic Study of Anti-inflammatory Effects of Fevipiprant in Patients With Eosinophilic Asthma
More Information

Bucillamine in Treatment of Patients With COVID-19
More Information

Evaluation of the Efficacy and Safety of VX-864 in Subjects With the PiZZ Genotype
More Information

A Study to Evaluate Efficacy and Safety of VX-864 in Participants With the PiZZ Genotype
More Information

Cardiology

DETERMINE-preserved – Dapagliflozin Effect on Exercise Capacity Using a 6-minute Walk Test in Patients With Heart Failure With Preserved Ejection Fraction
More Information

Study of Verinurad in Heart Failure With Preserved Ejection Fraction (AMETHYST)
More Information

Rheumatology

A Study to Assess Efficay and Safety of LC350189 Different Doses in Gout Patients With Hyperuricemia
More Information